Selank Nasal Spray: What Stability and Storage Claims Need to Show
A clinical study is not a stability study
The Selank anxiety study by Zozulia and colleagues assessed clinical and biological outcomes in a defined patient group. It did not establish storage conditions for arbitrary vendor-supplied nasal sprays. [1]
That distinction matters when a product page cites clinical research next to a precise shelf-life claim. The paper may concern the peptide without testing the claim next to which it appears.
What does stability testing measure?
A stability program examines whether a defined product continues to meet relevant specifications over time. The formulation, container, storage conditions, and test methods are part of that assessment. FDA's Q1A(R2) guidance describes the framework for drug stability testing. [2]
For a nasal product, several questions may need separate answers: chemical identity, concentration, degradation products, microbiological quality, and delivery performance. A result for one does not automatically settle the others.
| Claim or observation | What remains unknown |
|---|---|
| A sample had high purity when tested | How the finished formulation changes over time |
| The solution looks clear | Whether concentration, quality, and microbiological specifications are met |
| A preservative is present | Whether preservation is effective in that formulation |
| A supplier gives a storage period | Whether data support the stated conditions and container |
| A peptide is chemically related to another | Whether the two products have similar stability |
Premixed spray and reconstituted powder are different products
A finished nasal spray may contain buffers, preservatives, or other excipients. A powder combined with a liquid is a different preparation unless the complete formulation and process match. Even the delivery device can be relevant to product performance.
Consequently, a shelf-life statement for one cannot simply be transferred to the other. Nor can a period used for a different peptide or an approved nasal medicine be adopted as a Selank standard.
Why a certificate is only part of the evidence
A certificate of analysis describes particular testing. It may establish that the tested sample met stated criteria at a particular time. It is not automatically a longitudinal stability study or a validation of what happens after a container is opened.
To support a shelf-life conclusion, the evidence would need to address the same finished product, packaging, and conditions as the claim. A certificate without those data cannot supply an expiration window merely because it includes a purity percentage.
Frequently asked questions
Can refrigeration establish a safe shelf life?
No. A temperature choice alone cannot demonstrate the stability or quality of a particular preparation. The relationship needs product-specific evidence.
Can a clear appearance prove the spray is usable?
No. Visual inspection cannot verify all chemical or microbiological properties. An absence of visible change is not a complete quality test.
Does the absence of a cited stability study prove instant degradation?
No. It means this article cannot assign a reliable storage period. Unknown stability should not be converted into either a precise lifespan or a claim of immediate failure.
Is a general mixing recipe enough?
No. A recipe describes a process. It does not demonstrate the resulting product's identity, stability, or delivery performance over time.
